Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Recruiting 32Completed 24Unknown 19Active not recruiting 19Terminated 6Not yet recruiting 4Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 10Carcinoma, Hepatocellular 9Neoplasm Metastasis 7Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Breast Neoplasms 3Glioblastoma 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Radiotherapy 1Prostate Cancer Metastatic 1Ovarian Neoplasms 1Neoplasm, Residual 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1

Interventions

Docetaxel 11Prednisone 10Leuprolide 10Magnetic Resonance Spectroscopy 9bicalutamide 8Radiotherapy 7Abiraterone Acetate 7Biopsy 6gallium 68 PSMA-11 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Surveys and Questionnaires 5Metformin 5Goserelin 5radium Ra 223 dichloride 4enzalutamide 4apalutamide 4Specimen Handling 4Injections 4Androgen Antagonists 4pembrolizumab 3orteronel 3cabazitaxel 3abiraterone 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pioglitazone 3Paclitaxel 3Exercise 3Brachytherapy 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × Radiosurgery × Clear all
NCT03477864 2025-04-29

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Thomas Jefferson University

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT04399824 2020-11-06

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Jonsson Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03748719 2020-05-22

Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡